Document is current

Article History

Received: 5 September 2023

Accepted: 19 February 2025

First Online: 10 March 2025

Declarations

:

: Drs. Busner and Daniel are employees or consultants and hold equity in Signant Health. Dr. Youngstrom has received royalties from the American Psychological Association and Guilford Press, consulted with Signant Health about psychological assessment, and received funding from NIMH. He is the founder and Executive Director of Helping Give Away Psychological Science (HGAPS.org). Dr. Findling receives or has received research support, acted as a consultant and/or has received honoraria from Abbvie, Acadia, Adamas, Afecta, Ajna, Akili, Alkermes, Allergan, American Academy of Child & Adolescent Psychiatry, American Psychiatric Press, Arbor, Axsome, BioXcel, Idorsia, Intracellular Therapies, Iqvia, Lundbeck, Medavante Prophase, MJH Life Sciences, Neurim, NIH, Novartis, Otsuka, Oxford University Press, PaxMedica, PCORI, Pfizer, Physicians’ Postgraduate Press, Radius, Receptor Life Sciences, Sage, Signant Health, Sunovion, Supernus Pharmaceuticals, Syneos, Takeda, Tris, and Viatris. Mr. Langfus has no competing interests or disclosures.

: The original aripiprazole clinical trial was conducted under the IRB/EC authority of the individual investigators. The secondary analyses that comprise the current work were reviewed and approved by the University of North Carolina, Chapel Hill, IRB.